| Item Type | Name |
|
Academic Article
|
Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
|
|
Academic Article
|
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
|
|
Academic Article
|
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
|
|
Academic Article
|
Surrogate marker for predicting the virus binding of urogenital cancer cells during adenovirus-based gene therapy.
|
|
Academic Article
|
Factors influencing the outcomes of penile prosthesis surgery at a teaching institution.
|
|
Academic Article
|
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
|
|
Academic Article
|
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
|
|
Academic Article
|
Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
|
|
Academic Article
|
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
|
|
Academic Article
|
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.
|
|
Academic Article
|
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
|
|
Academic Article
|
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
|
|
Academic Article
|
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.
|
|
Academic Article
|
The effect of finasteride in men with benign prostatic hyperplasia. 1992.
|
|
Academic Article
|
Heterogeneity of 5 alpha-reductase gene expression in benign prostatic hyperplasia.
|
|
Academic Article
|
Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.
|
|
Academic Article
|
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
|
|
Academic Article
|
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.
|
|
Academic Article
|
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
|
|
Academic Article
|
The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate.
|
|
Academic Article
|
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
|
|
Academic Article
|
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
|
|
Academic Article
|
Biopsy misidentification identified by DNA profiling in a large multicenter trial.
|
|
Academic Article
|
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
|
|
Concept
|
Survival Rate
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Urinary Bladder Neck Obstruction
|
|
Concept
|
Urogenital Neoplasms
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Urination Disorders
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Urinary Retention
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Gene Expression Profiling
|
|
Concept
|
Specimen Handling
|
|
Concept
|
Receptors, Urokinase Plasminogen Activator
|
|
Concept
|
Patient Selection
|
|
Concept
|
Sexual Dysfunctions, Psychological
|
|
Concept
|
Genes, Tumor Suppressor
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Sequence Homology, Amino Acid
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Stromal Cells
|
|
Concept
|
Urokinase-Type Plasminogen Activator
|
|
Concept
|
Ultrasonography
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Grant
|
MEDICAL THERAPY OF BENIGN PROSTATIC HYPERPLASIA
|
|
Grant
|
CONFERENCE--ADVANCES IN BENIGN PROSTATIC HYPERPLASIA RES
|
|
Grant
|
MTOPS Prostate Samples Analysis Consortium
|